Atom Investors’s Agilon Health AGL Stock Holding History

Atom Investors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,672	Closed	-$1.09M	–	266
2021 Q3	$1.09M	Buy	+1,672	New	+$1.43M	0.09%	126

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Atom Investors's AGL Position: Q4 2021 in Review

Atom Investors sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 1,672 shares — an estimated $1.09M sold.

Atom Investors first reported a position in AGL in Q3 2021 and held it in 1 quarter. The position peaked at $1.09M in Q3 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.

Atom Investors reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
Atom Investors sold 1,672 Agilon Health shares in Q4 2021, an estimated $1.09M.
Atom Investors first reported a position in Agilon Health in Q3 2021 and held it in 1 quarter.
Atom Investors's Agilon Health position peaked at $1.09M in Q3 2021.
132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.

Based on Atom Investors's 13F filing for Q4 2021, filed 14 Feb 2022.